[Market Focus] DongKook Pharmaceutical Jumps 7% on Expectations of Rising Cosmetics Exports

DongKook Pharmaceutical is showing a surge of over 7% during trading on April 6. Market sentiment appears to have been boosted by the securities industry’s positive outlook, following consistent annual growth in the company’s cosmetics exports.

As of 10:43 a.m. on this day, DongKook Pharmaceutical was trading at 29,450 won on the Korea Exchange, up 7.48% from the previous session.

This rise is interpreted as being influenced by analysts’ expectations that the company’s share price will continue to climb, driven by robust sales performance in the cosmetics segment.

In a recent report, LS Securities researcher Jeong Hong-sik stated, “DongKook Pharmaceutical’s cosmetics export volume was 16.3 billion won in 2024, 30 billion won last year, and is projected to exceed 100 billion won this year,” adding, “The expansion in exports is expected to significantly improve the profitability of the cosmetics division compared to last year, due to economies of scale.”

In the same report, Jeong raised DongKook Pharmaceutical’s target share price to 45,000 won and maintained a ‘buy’ investment opinion.

This content was produced with the assistance of AI translation services.